Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase protein expression on survival in adjuvantly treated stage III colon cancer patients.

Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase protein expression on survival in adjuvantly treated stage III colon cancer patients.

Item
http://www.wikidata.org/entity/Q46596760
Clinical management of localized colon cancer with capecitabineFOLFOX/FOLFIRI pharmacogenetics: the call for a personalized approach in colorectal cancer therapyThymidylate synthase expression and prognosis in colorectal cancer: a meta-analysis of colorectal cancer survival data.ERCC1 and BRCA1 mRNA expression levels in metastatic malignant effusions is associated with chemosensitivity to cisplatin and/or docetaxel.Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 yearsPrognostic significance of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase protein expression in colorectal cancer patients treated with or without 5-fluorouracil-based chemotherapy.Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discovery.Predictive diagnostics in colorectal cancer: impact of genetic polymorphisms on individual outcomes and treatment with fluoropyrimidine-based chemotherapy.Abundant Fas expression by gastrointestinal stromal tumours may serve as a therapeutic target for MegaFasL.Clinical biomarkers in oncology: focus on colorectal cancer.5-Fluorouracil pharmacogenomics: still rocking after all these years?Predictive biomarkers with potential of converting conventional chemotherapy to targeted therapy in patients with metastatic colorectal cancer.Correlation between thymidylate synthase gene variants, RNA and protein levels in primary colorectal adenocarcinomas.Evaluation of 5-fluorouracil metabolic enzymes as predictors of response to adjuvant chemotherapy outcomes in patients with stage II/III colorectal cancer: a decision-curve analysis.Insulin-like growth factors and insulin-like growth factor-binding proteins in relation to disease status and incidence of hypoglycaemia in patients with a gastrointestinal stromal tumour.Frequent intragenic rearrangements of DPYD in colorectal tumours
P2860

Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase protein expression on survival in adjuvantly treated stage III colon cancer patients.

Item
http://www.wikidata.org/entity/Q46596760
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Predictive value of thymidylat ...... age III colon cancer patients.
@en
Predictive value of thymidylat ...... age III colon cancer patients.
@nl
type
label
Predictive value of thymidylat ...... age III colon cancer patients.
@en
Predictive value of thymidylat ...... age III colon cancer patients.
@nl
prefLabel
Predictive value of thymidylat ...... age III colon cancer patients.
@en
Predictive value of thymidylat ...... age III colon cancer patients.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Predictive value of thymidylat ...... age III colon cancer patients.
@en
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698